Literature DB >> 15505272

Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis.

Monika Spurek1, Regina Taylor-Gjevre, Stan Van Uum, Hasnain M Khandwala.   

Abstract

Adrenomyeloneuropathy is a varient of adrenoleukodystrophy, both of which are rare inherited disorders of peroxisomes characterized by the accumulation of very-long-chain fatty acids in plasma, the central and peripheral nervous systems, adrenal glands and testes, which leads to dysfunction of these organs and systems. In this article, we describe an illustrative case of adrenomyeloneuropathy and discuss the clinical presentation, diagnosis and management of the 2 disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15505272      PMCID: PMC526335          DOI: 10.1503/cmaj.1032006

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  31 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.

Authors:  J W Griffin; E Goren; H Schaumburg; W K Engel; L Loriaux
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

3.  Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Authors:  L Bezman; A B Moser; G V Raymond; P Rinaldo; P A Watkins; K D Smith; N E Kass; H W Moser
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

4.  Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression.

Authors:  D A Stumpf; A Hayward; R Haas; M Frost; H H Schaumburg
Journal:  Arch Neurol       Date:  1981-01

5.  Histochemical characteristics of the striated inclusions of adrenoleukodystrophy.

Authors:  A B Johnson; H H Schaumburg; J M Powers
Journal:  J Histochem Cytochem       Date:  1976-06       Impact factor: 2.479

6.  Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.

Authors:  B M van Geel; J Assies; G J Weverling; P G Barth
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

7.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

8.  Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein.

Authors:  M J Ligtenberg; S Kemp; C O Sarde; B M van Geel; W J Kleijer; P G Barth; J L Mandel; B A van Oost; P A Bolhuis
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  The testis in adreno-leukodystrophy.

Authors:  J M Powers; H H Schaumburg
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

10.  Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  G Uziel; E Bertini; P Bardelli; M Rimoldi; M Gambetti
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

View more
  3 in total

1.  Adrenomyeloneuropathy presenting with adrenal insufficiency.

Authors:  Hee Dong Park; Sang Jun Park; Yong Min Choi; Jin Ho Kang
Journal:  Ann Rehabil Med       Date:  2013-08-26

2.  A family with combined mutations of the hemophilia A and X-linked adrenoleukodystrophy genes.

Authors:  Brent L Fogel; Pari Young; Arthur R Thompson; Susan Perlman
Journal:  Neurogenetics       Date:  2008-05-15       Impact factor: 2.660

3.  Madarosis: a marker of many maladies.

Authors:  Annapurna Kumar; Kaliaperumal Karthikeyan
Journal:  Int J Trichology       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.